CTCFL and malignant colon neoplasm: To further verify the significance of BORIS in colorectal cancer, the expression and sub-cellular localization of BORIS were observed by immunohistochemistry (IHC) assay in 180 clinical colon samples, which included 100 cancer tissues and 80 adjacent normal tissues collected from 100 colon cancer patients (Table 1).